Human SMOOTHENED inhibits human immunodeficiency virus type 1 infection. 2017

Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. Electronic address: takeshi-yoshida@umin.ac.jp.

Human SMOOTHENED (SMO) was identified by expression cloning as a new host factor that inhibits HIV-1 infection. Forced expression of SMO inhibited HIV-1 replication and infection with a single-round lentiviral vector, but not infection with a murine leukemia virus-based retroviral vector in human MT-4 T cells. Quantitative PCR analyses revealed that stable expression of SMO impaired formation of the integrated form of lentiviral DNA, but did not interrupt reverse transcription. This inhibition was evident in MT-4 and HUT102 human T cell lines expressing low levels of SMO mRNA, but not in SupT1 or Jurkat T cell lines expressing higher levels of SMO mRNA. Depletion of SMO mRNA in Jurkat cells facilitated HIV-1 vector infection, suggesting that endogenous SMO plays a role in limiting lentiviral infection. These results suggest that SMO inhibits HIV-1 replication after completion of reverse transcription but before integration.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072086 Smoothened Receptor A frizzled-like, G-protein-coupled receptor that associates with PATCHED RECEPTORS to transduce signals from HEDGEHOG PROTEINS and initiate hedgehog signaling to ZINC FINGER PROTEIN GLI1. It may normally inhibit signaling in the absence of SONIC HEDGEHOG PROTEIN binding to PATCHED RECEPTOR-1. Smoothened Protein,Smoothened Receptors,Receptor, Smoothened,Receptors, Smoothened
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D053586 Virus Internalization The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by translocation of the whole virus across the cell membrane, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by fusion of the membrane of infected cells with the membrane of non-infected cells causing SYNCYTIA to be formed. Viral Entry,Viral Internalization,Viral Membrane Fusion,Virus Entry,Virus Membrane Fusion,Entry, Viral,Entry, Virus,Fusion, Viral Membrane,Internalization, Viral,Internalization, Virus,Membrane Fusion, Viral
D019169 Jurkat Cells A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation. Cell, Jurkat,Cells, Jurkat,Jurkat Cell

Related Publications

Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
March 2008, AIDS (London, England),
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
April 2009, Journal of virology,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
January 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
June 2005, Current HIV/AIDS reports,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
July 1998, The New England journal of medicine,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
February 2006, Virology,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
January 1995, Annales de dermatologie et de venereologie,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
January 1994, The Journal of general virology,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
October 2022, Infectious diseases & immunity,
Takeshi Yoshida, and Akiko Hamano, and Asuka Ueda, and Hiroaki Takeuchi, and Shoji Yamaoka
November 1988, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!